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Background. Human leukocyte antigen (HLA) alleles code for proteins that are involved in the recognition of
foreign antigens and activation of the immune system. The frequency of HLA alleles varies across different
populations.
Objective. To describe the frequency of HLA alleles in a population of Inuit women of Nunavik, Quebec,
Canada.
Design. A cohort of women was recruited from 4 different communities between January 2002 and December
2007. HLA-B*07, HLA-DQB1*03, DQB1*06:02, DRB1*13 and DRB1*15:01 alleles were typed by PCR
sequence-specific primers (PCR-SSP) and HLA-E and G alleles were type by DNA-sequencing procedures.
Results. We obtained data on 524 participants. The most frequent HLA alleles in this population were HLA-
E*01:03, HLA-G*01:04:01 and HLA-DQB1*03, and they were found in 89, 75 and 94% of the population,
respectively.
Conclusions. The distribution of HLA alleles in Nunavik, Quebec is unique when compared to other
populations in Canada or around the world.
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N
unavik is the arctic and sub-arctic region of
Northern Quebec, Canada. For 4,000 years this
region has been inhabited by nomads, the first
residents of Nunavik travelled from Asia to North
America via the Bering Strait. The Inuit people are
descendants of the Thule, who appeared in the western
part of Northern Canada around 1,000 AD. The earliest
archaeological evidence of the Thule people in Nunavik
dates back to around the thirteenth century (1,2). Today,
Nunavik’s population of 11,000 lives in 14 communi-
ties along the coast of Hudson Bay, Hudson Straight
and Ungava Bay. Ninety percent of the population of
Nunavik self-identifies as Inuit. This population is not
onlygeographically isolated but has a unique cultural and
socio-demographic make-up (1,3) (Fig. 1).
Human leukocyte antigens (HLA) are part of the major
histocompatibility complex (MHC) in humans. The HLA
family of genes code for cell surface proteins, which
present antigens (foreign or self) to immune cells, and
other proteins involved in internal processing of antigens
(46). HLA class I proteins include HLA-A, B, C, E, F
and G and are expressed on all nucleated cells. Class II
proteins include HLA-DP, DQ and DRand are expressed
on immune cells (lymphocytes and macrophages) (4).
HLA genes are highly polymorphic allowing HLA
proteins to bind to and present a variety of antigenic
proteins to immune cells (4). Determining which HLA
alleles are present in a population (and their frequencies)
could provide insights into the origin of Native American
groups, the evolution of HLA polymorphisms (a point
in a DNA sequence where there is variation), and the
population’s genetic susceptibility to disease. Polymorph-
isms in various HLA genes have been linked with
susceptibility to viral infections such as HPV, HIV, HBV
and HCV (48). It is hypothesised that individuals with
HLA polymorphisms with a higher binding affinity to a
particular viral antigen arebetter at clearing the infection.
An allele is an alternative form or version of a gene.
An individual’s genotype is the 2 alleles inherited for a
particular gene. If an individual is homozygous for a
 RESEARCH IN THE NORTH
Int J Circumpolar Health 2013. # 2013 Stephanie Metcalfe et al. This is an Open Access article distributed under the terms of the Creative Commons
Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and
reproduction in any medium, provided the original work is properly cited.
1
Citation: Int J Circumpolar Health 2013, 72: 21350 - http://dx.doi.org/10.3402/ijch.v72i0.21350
(page number not for citation purpose)gene, both their alleles are the same and if they are
heterozygous they have 2 different versions of the allele.
A haplotype is a set of DNA polymorphisms along a
chromosome that tend to be inherited together (9). HLA
alleles are named in this way: HLAlocus name*allele
number. The first 2 numbers after the asterisk (*) are the
allele number and any numbers after that are the allele
subtype (10). For example HLA-G*01:04:01, 01 is the
allele number and 04:01 is the allele subtype.
Methods
The data used for this analysis were taken from a
prospective cohort of Inuit women used to study the
prevalence, incidence and determinants of human papil-
lomavirus (HPV) infection. Details of this study havebeen
previously published (11). Nurse practitioners system-
atically asked women aged 1569 presenting for a
regularly scheduled Pap test at a clinic in one of the 4
participating communities between January 2002 and
December 2007 if they wanted to participate. All eligible
women providedwritten consent, and ethics approval was
obtained from the McGill Institutional Review Board and
the Tulattavik Health Center.
At enrolment, cervical specimens were collected and
used for HLA typing. Low-resolution typing was used to
determine the presence of HLA-B*07 and 4 class II
alleles: HLA-DQB1*03, DQB1*06:02, DRB1*13 and
DRB1*15:01 (these alleles were associated with cervical
cancer in previous literature and were chosen a priori).
They were typed using a PCR technique that used
sequence-specific primers (PCR-SSP), according to a
well-established procedure where pairs of oligonucleo-
tides were used as primers for amplification of the HLA
alleles (12,13). Class I HLA-E and G alleles were typed
using high-resolution DNA typing; therefore, all of the
alleles present in the population were captured. HLA-G
and HLA-E alleles were determined through direct DNA
sequencing of the nucleotide regions encompassing the
HLA-E exon 3 (218bp) and HLA-G exons 24 (1718bp)
using purified DNA from cervical samples (14).
Results
The study population comprised 524 women. The most
common class I and II alleles were HLA-E*01:03 and
HLA-DQB1*03 which were found in 89.3 and 94.2% of
women, respectively. HLA-B*07, DQB1*06:02, DRB1*
13 and DRB1*15:01 were all found in B5% of the
women in this population (Table I). Table II shows the
HLA haplotypes of the 5 alleles that were chosen a
priori (HLA-B*07, DQB1*03, DQB1*06:02, DRB1*13,
Fig. 1. The location of Nunavik, Quebec in North America.
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more than 5% of the population.
Two HLA-E alleles and 8 HLA-G alleles were found in
the population of Nunavik. HLA-E*01:01, the wild type
allele, made up 32.7% of the alleles in the population and
HLA-E*01:03 made up 66.2%. The most common HLA-
G alleles were: HLA-G*01:04:01 (50.4%), G*01:01:01
(31.4%) and G*01:01:02 (15.2%) (Table I). A total of
47.9% of the HLA-G alleles in this population were from
the wild type HLA-G*01:01 lineage (includes HLA-
G*01:01:01, G*01:01:02, G*01:01:03 and G*01:01:08).
Table III shows the frequencies of the genotypes of HLA-
G*01:01:01, G*01:01:02 and G*01:04:01.
Discussion
This is the first known study to determine the frequency
of HLA alleles in the Inuit of Nunavik, Quebec. A study
by Leffell et al. investigated the frequency of HLA alleles
in the Yup’ik Inuit population of Alaska in which HLA-
B*07:02, DRB1*15:01, DRB1*13:01 and DQB1*06:02
were present in less than 2% of the population and
DQB1*03:01 had a frequency 61.7% (15). On the basis of
the distribution of these 5 alleles, the Yup’ik population
of Alaska and the Inuits of Nunavik are somewhat
similar. Unfortunately, the Alaskan study did not type
for HLA-E or G.
In women living in Montreal, Quebec, the HLAB*07,
HLA-DQB1*06:02, DRB1*13 and DRB1*15:01 alleles
were all more frequent than in Nunavik. In 2 Montreal
populations, their frequencies were 15, 20, 20 and 23%,
respectively (13,16). HLA-DQB1*03 was found in
around 60% of the Montreal populations, whereas it
was found in almost all of the Inuit women (94%). The
reported haplotypes of these 5 alleles were again found in
a greater proportion of the Montreal population than the
Nunavik population (13,16).
The HLA-G*01:01:01 and HLA-G*01:01:02 alleles
were prevalent in Montreal women (45 and 24%), but
HLA-G*01:04:01 (which was the most prevalent HLA-G
allele in Nunavik, 50%) made up only 9% of the alleles in
the population (17). A total of 21, 7 and 2% of the
Montreal population had homozygous HLA-G*01:01:01,
G*01:01:02 and G*01:04:01 genotypes, respectively,
and 46, 34 and 14% had heterozygous G*01:01:01,
G*01:01:02 and G*01:04:01 genotypes, respectively (17).
Table I. The frequency of HLA alleles, both the frequency of
women with the allele (N524) and for HLA-G and E the
frequency of alleles in the population (N1048)
Frequency of
women with
HLA allele
Frequency of the
HLA alleles in the
population
HLA allele n N* % n N %
HLA-B*07 23 514 4.47
HLA-E*01:01 293 524 55.92 343 1048 32.73
HLA-E*01:03 468 524 89.31 693 1048 66.13
HLA-G*01:01:01 278 524 52.86 328 1048 31.30
HLA-G*01:01:02 146 524 28.82 159 1048 15.17
HLA-G*01:01:03 11 524 2.10 11 1048 1.05
HLA-G*01:01:08 4 524 0.76 4 1048 0.38
HLA-G*01:03 4 524 0.76 4 1048 0.38
HLA-G*01:04:01 399 524 75.38 526 1048 50.19
HLA-G*01:06 13 524 2.48 14 1048 1.34
HLA-G*01:07 1 524 0.19 1 1048 0.10
HLA-DQB1*03 486 516 94.19
HLA-DQB1*06:02 19 523 3.63
HLA-DRB1*13 25 532 4.70
HLA-DRB1*15:01 20 527 3.80
*The denominator is not always consistent because some of the
specimens could not be tested by PCR.
Table II. The frequency of women with HLA haplotypes
(N524)
HLA haplotype n N* %
B*07-DQB1*03 18 494 3.64
B*07-DQB1*06:02 8 479 1.67
B*07-DRB1*13 1 510 0.20
B*07-DRB1*15:01 8 502 1.59
DQB1*03-DQB1*06:02 13 505 2.57
DQB1*03-DRB1*13 15 511 2.94
DQB1*03-DRB1*15:01 14 507 2.76
DQB1*06:02-DRB1*13 1 517 0.19
DRB1*15:01-DQB1*06:02 19 511 3.72
DRB1*15:01-DRB1*13 1 520 0.19
B*07-DRB1*15:01-DQB1*06:02 8 487 1.64
*The denominator is not always consistent because some of the
specimens could not be amplified.
Table III. The frequency of the homozygous and heterozygous
genotypes for the 3 most common HLA-G alleles (N524)
HLA-genotype n N %
G*01:01:01
Homozygous 51 524 9.73
Heterozygous 227 524 43.32
Absent 244 524 46.56
G*01:01:02
Homozygous 8 524 1.53
Heterozygous 138 524 26.34
Absent 376 524 71.76
G*01:04:01
Homozygous 131 524 25.00
Heterozygous 268 524 51.15
Absent 125 524 23.85
The frequency of HLA alleles
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both heterozygote and homozygote HLA-G*01:01:01
and G*01:01:02 genotypes than the Montreal women.
The heterozygote and homozygote and G*01:04:01 geno-
types were found in 51 and 25% of the Nunavik popu-
lation, a much greater proportion than in the Montreal
population (17).
A study by Matte et al. compiled the frequencies of
the HLA-G allele from 10 populations around the world
(18). The most common alleles found were HLA-
G*01:01:01, G*01:01:02 and G*01:04:01. In comparison,
the Nunavik population had lower frequency of HLA-
G*01:01:01 and G*01:01:02 and a higher frequency of
HLA-G*01:04:01 than the majority of the populations
studied by Matte et al. In all populations but one, the
most frequent allele was G*01:01:01 (in the German/
Croatian population, HLA-G*01:01:02 was the most
frequent allele) (18). In the Inuit population of Nunavik,
the most common allele was HLA-G*01:04:01 (50%)
which makes it unique among these populations.
Limitations to this study include the possibility of
regional differences of HLA frequencies within the
Nunavik territory and non-random recruitment. In con-
clusion, the frequency of HLA alleles in Nunavik, Quebec
is different from that found in other Canadian popula-
tions and other populations around the world. Two alleles
in particular, HLA-G*01:04:01 and HLA-DQB1*03
(found in 76 and 94% of individuals, respectively) were
found more frequently in the Nunavik population than
in other populations which have been studied. Clinical
significance of these findings in terms of the potential
impact on HPV prevalence or persistence will be subse-
quently explored. These regional variations could have an
impact on disease outcome including not only HPV but
also other morbidities such as autoimmune disorders and
vaccine efficacy.
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